Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.60
0.95%
Gold
2,635.50
0.23%
Copper
4.11
0.28%
Oil
70.14
0.83%
Bitcoin
98,489.02
3.94%
USD/AUD
0.62
(0.3%)
FTSE 100
8,136.99
0.42%
Nikkei 225
39,036.85
(0.44%)
Dow Jones
43,208.14
0.68%
Hang Seng
20,098.29
0.94%

Cleo Diagnostics (ASX: $COV) expands clinical trial for ovarian cancer test

Cleo Diagnostics expands ovarian cancer trial


Cleo Diagnostics (ASX:COV) has announced a significant expansion of its clinical trial for an ovarian cancer blood test. The company is partnering with Siles Health, a network of women's health and ultrasound clinics in Melbourne and regional Victoria, to enhance the trial. This move aims to provide additional insights into clinical workflows and increase the patient sample size to support their U.S. FDA-enabling trial.

Overview of Cleo Diagnostics' trial expansion and future goals


Cleo Diagnostics (ASX:COV) is expanding its ovarian cancer blood test trial by partnering with Siles Health. This collaboration aims to enhance the trial by increasing the patient cohort and gathering insights into clinical workflows. The test, based on the CXCL10 biomarker, seeks to improve early detection of ovarian cancer. Cleo's broader strategy includes market adoption and global optimization of the test. The company is focused on transforming diagnostic practices and improving outcomes for women's health.

Insights from key stakeholders on the partnership


Associate Professor Charles Siles expressed enthusiasm for the collaboration, citing shared goals in advancing women's health. CEO Richard Allman emphasized the importance of partnerships in transforming ovarian cancer diagnostics and achieving market adoption, especially in the U.S.

CLEO DIAGNOSTICS LTD
COV | ASX
0.355-0.01(-2.74%)
At close 23/12 (AEDT)
Market cap
$45.6M
Volume
72,867
DY Yield
PE Ratio
52 Week Range
0.14 - 0.48
1YR Return
N / A

0 Comments
Inline Feedbacks
View all comments
Social Media Auto Publish Powered By : XYZScripts.com

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions